Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in J Nephrol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    April 2018
  1. L'IMPERIO V, Pieruzzi F, Sinico RA, Nebuloni M, et al
    Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    J Nephrol. 2018 Apr 6. pii: 10.1007/s40620-018-0489.
    PubMed     Text format     Abstract available


    March 2018
  2. MILILLO A, Molinario C, Costanzi S, Vischini G, et al
    Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schonlein purpura.
    J Nephrol. 2018 Mar 1. pii: 10.1007/s40620-018-0482.
    PubMed     Text format     Abstract available


    December 2017
  3. CHEN D, Hu W
    Lupus podocytopathy: a distinct entity of lupus nephritis.
    J Nephrol. 2017 Dec 22. pii: 10.1007/s40620-017-0463.
    PubMed     Text format     Abstract available


    November 2017
  4. XU K, Zhang L, Ding J, Wang S, et al
    Value of the Oxford classification of IgA nephropathy in children with Henoch-Schonlein purpura nephritis.
    J Nephrol. 2017 Nov 28. pii: 10.1007/s40620-017-0457.
    PubMed     Text format     Abstract available


    October 2017
  5. RADICE A, Pieruzzi F, Trezzi B, Ghiggeri G, et al
    Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    J Nephrol. 2017 Oct 28. doi: 10.1007/s40620-017-0451.
    PubMed     Text format     Abstract available


    September 2017
  6. ANGIOI A, Lepori N, Lopez AC, Sethi S, et al
    Treatment of primary membranous nephropathy: where are we now?
    J Nephrol. 2017 Sep 5. doi: 10.1007/s40620-017-0427.
    PubMed     Text format     Abstract available


    February 2017
  7. LUAN JJ, Xing GQ
    Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.
    J Nephrol. 2017;30:63-71.
    PubMed     Text format     Abstract available


  8. GEETHA D, Lee SM, Shah S, Rahman HM, et al
    Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis.
    J Nephrol. 2017;30:147-153.
    PubMed     Text format     Abstract available


    November 2016
  9. COPPO R
    Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  10. MARITATI F, Iannuzzella F, Pavia MP, Pasquali S, et al
    Kidney involvement in medium- and large-vessel vasculitis.
    J Nephrol. 2016;29:495-505.
    PubMed     Text format     Abstract available


  11. QUATTROCCHIO G, Roccatello D
    IgG4-related nephropathy.
    J Nephrol. 2016;29:487-93.
    PubMed     Text format     Abstract available


    May 2016
  12. MESSINA M, di Vico MC, Ariaudo C, Mazzucco G, et al
    Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


  13. MARCANTONI C, Emmanuele C, Scolari F
    Renal involvement in primary antiphospholipid syndrome.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


  14. MORONI G, Raffiotta F, Ponticelli C
    Remission and withdrawal of therapy in lupus nephritis.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


  15. MAIXNEROVA D, Reily C, Bian Q, Neprasova M, et al
    Markers for the progression of IgA nephropathy.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  16. GEETHA D, Hruskova Z, Segelmark M, Hogan J, et al
    Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    J Nephrol. 2016;29:195-201.
    PubMed     Text format     Abstract available


    January 2016
  17. MURTAS C, Ghiggeri GM
    Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


  18. ROLLINO C, Vischini G, Coppo R
    IgA nephropathy and infections.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


  19. POZZI C, Sarcina C, Ferrario F
    Treatment of IgA nephropathy with renal insufficiency.
    J Nephrol. 2016.
    PubMed     Text format     Abstract available


    November 2015
  20. DIAS CB, Malafronte P, Lee J, Resende A, et al
    Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis.
    J Nephrol. 2015.
    PubMed     Text format     Abstract available


  21. FERIOZZI S, Polci R
    The role of tonsillectomy in IgA nephropathy.
    J Nephrol. 2015.
    PubMed     Text format     Abstract available


  22. POZZI C
    Treatment of IgA nephropathy.
    J Nephrol. 2015.
    PubMed     Text format     Abstract available


  23. LECHNER SM, Papista C, Chemouny JM, Berthelot L, et al
    Role of IgA receptors in the pathogenesis of IgA nephropathy.
    J Nephrol. 2015.
    PubMed     Text format     Abstract available


  24. DAHA MR, van Kooten C
    Role of complement in IgA nephropathy.
    J Nephrol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  25. SUN S, Zhao A, Li R, Du R, et al
    CD147 renal expression as a biomarker for progressive IgAN.
    J Nephrol. 2015;28:307-14.
    PubMed     Text format     Abstract available


    April 2015
  26. HIKI Y, Hori H, Yamamoto K, Yamamoto Y, et al
    Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region.
    J Nephrol. 2015;28:181-6.
    PubMed     Text format     Abstract available


    February 2015
  27. GEETHA D, Kallenberg C, Stone JH, Salama AD, et al
    Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
    J Nephrol. 2015;28:17-27.
    PubMed     Text format     Abstract available


  28. VERGANO L, Loiacono E, Albera R, Coppo R, et al
    Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy?
    J Nephrol. 2015;28:51-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: